Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding

AIDS. 2016 Apr 24;30(7):1144-6. doi: 10.1097/QAD.0000000000001040.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / methods*
  • HIV Infections / drug therapy*
  • HIV Infections / virology*
  • Humans
  • Male
  • Raltegravir Potassium / therapeutic use*
  • Semen / virology*
  • Treatment Outcome
  • Virus Shedding*

Substances

  • Anti-Retroviral Agents
  • Raltegravir Potassium